Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 43-48 , 30 October 2009

Inhibition of experimental autoimmune uveitis by amino acid copolymers

  • Hongen Yin

      Affiliations

    • Laboratory of Immunology, National Eye Institute, NIH, 10 Center Drive, Bethesda, MD 20892, United States
    • ,
  • Barbara P. Vistica

      Affiliations

    • Laboratory of Immunology, National Eye Institute, NIH, 10 Center Drive, Bethesda, MD 20892, United States
    • ,
  • Chi-Chao Chan

      Affiliations

    • Laboratory of Immunology, National Eye Institute, NIH, 10 Center Drive, Bethesda, MD 20892, United States
    • ,
  • Jack L. Strominger

      Affiliations

    • Department of Molecular and Cellular Biology, Harvard University, 7 Divinity Avenue, Cambridge MA 02138, United States
    • ,
  • Igal Gery

      Affiliations

    • Laboratory of Immunology, National Eye Institute, NIH, 10 Center Drive, Bethesda, MD 20892, United States
    • Corresponding Author InformationCorresponding author: Tel.: +1 301 496 4159; fax: +1 301 480 7950.

Received 20 May 2009 ,Revised 27 July 2009 ,Accepted 6 August 2009.

References 

  1. Adamus G, Chan CC. Experimental autoimmune uveitides: multiple antigens, diverse diseases. Int. Rev. Immunol. 2002;21:209–229
  2. Aharoni R, Teitelbaum D, Leitner O, Meshorer A, Sela M, Arnon R. Specific Th2 cells accumulate in the central nervous system of mice protected against experimental autoimmune encephalomyelitis by copolymer 1. Proc. Natl. Acad. Sci. U. S. A. 2000;97:11472–11477
  3. Arnon R, Aharoni R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc. Natl. Acad. Sci. U. S. A. 2004;101(Suppl 2):14593–14598
  4. Bettelli E, Oukka M, Kuchroo VK. T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 2007;8:345–350
  5. Caspi RR. Th1 and Th2 responses in pathogenesis and regulation of experimental autoimmune uveoretinitis. Int. Rev. Immunol. 2002;21:197–208
  6. de Vos AF, Fukushima A, Lobanoff MC, Vistica BP, Lai JC, Grivel JC, et al. Breakdown of tolerance to a neo-self antigen in double transgenic mice in which B cells present the antigen. J. Immunol. 2000;164:4594–4600
  7. Dhib-Jalbut S, Chen M, Said A, Zhan M, Johnson KP, Martin R. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype. J. Neuroimmunol. 2003;140:163–171
  8. Duda PW, Schmied MC, Cook SL, Krieger JI, Hafler DA. Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis. J. Clin. Invest. 2000;105:967–976
  9. Farina C, Weber MS, Meinl E, Wekerle H, Hohlfeld R. Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action. Lancet. Neurol. 2005;4:567–575
  10. Forrester JV, Liversidge J, Dua HS, Towler H, McMenamin PG. Comparison of clinical and experimental uveitis. Curr. Eye Res. 1990;9:75–84Suppl
  11. Foxman EF, Zhang M, Hurst SD, Muchamuel T, Shen D, Wawrousek EF, et al. Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation. J. Immunol. 2002;168:2483–2492
  12. Fridkis-Hareli M, Strominger JL. Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules. J. Immunol. 1998;160:4386–4397
  13. Fridkis-Hareli M, Teitelbaum D, Gurevich E, Pecht I, Brautbar C, Kwon OJ, et al. Direct binding of myelin basic protein and synthetic copolymer 1 to class II major histocompatibility complex molecules on living antigen-presenting cells — specificity and promiscuity. Proc. Natl. Acad. Sci. U. S. A. 1994;91:4872–4876
  14. Fridkis-Hareli M, Neveu JM, Robinson RA, Lane WS, Gauthier L, Wucherpfennig KW, et al. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules. J. Immunol. 1999;162:4697–4704
  15. Fridkis-Hareli M, Santambrogio L, Stern JN, Fugger L, Brosnan C, Strominger JL. Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. J. Clin. Invest. 2002;109:1635–1643
  16. Gery I, Nussenblatt RB, Chan CC, Caspi RR. Autoimmune disease of the eye. In:  Theofilopoulos AN,  Bona CA editor. The molecular pathology of autoimmune diseases. New York, NY: Taylor & Francis; 2002;p. 978–998
  17. Hong J, Li N, Zhang X, Zheng B, Zhang JZ. Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. U. S. A. 2005;102:6449–6454
  18. Hussien Y, Sanna A, Soderstrom M, Link H, Huang YM. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis. J. Neuroimmunol. 2001;121:102–110
  19. Illes Z, Stern JN, Reddy J, Waldner H, Mycko MP, Brosnan CF, et al. Modified amino acid copolymers suppress myelin basic protein 85–99-induced encephalomyelitis in humanized mice through different effects on T cells. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11749–11754
  20. Kim HJ, Ifergan I, Antel JP, Seguin R, Duddy M, Lapierre Y, et al. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J. Immunol. 2004;172:7144–7153
  21. Neuhaus O, Farina C, Yassouridis A, Wiendl H, Then Bergh F, Dose T, et al. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc. Natl. Acad. Sci. U. S. A. 2000;97:7452–7457
  22. Pepperberg DR, Okajima TL, Ripps H, Chader GJ, Wiggert B. Functional properties of interphotoreceptor retinoid-binding protein. Photochem. Photobiol. 1991;54:1057–1060
  23. Silver PB, Chan CC, Wiggert B, Caspi RR. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment. Invest. Ophthalmol. Vis. Sci. 1999;40:2898–2905
  24. Steinman L. A brief history of T(H)17, the first major revision in the T(H)1/T(H)2 hypothesis of T cell-mediated tissue damage. Nat. Med. 2007;13:139–145
  25. Stern JN, Illes Z, Reddy J, Keskin DB, Sheu E, Fridkis-Hareli M, et al. Amelioration of proteolipid protein 139–151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms. Proc. Natl. Acad. Sci. U. S. A. 2004;101:11743–11748
  26. Stern JN, Keskin DB, Zhang H, Lv H, Kato Z, Strominger JL. Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice. Proc. Natl. Acad. Sci. U. S. A. 2008;105:5172–5176
  27. Takase H, Yu CR, Liu X, Fujimoto C, Gery I, Egwuagu CE. Induction of suppressors of cytokine signaling (SOCS) in the retina during experimental autoimmune uveitis (EAU): potential neuroprotective role of SOCS proteins. J. Neuroimmunol. 2005;168:118–127
  28. Vieira PL, Heystek HC, Wormmeester J, Wierenga EA, Kapsenberg ML. Glatiramer acetate (copolymer-1, copaxone) promotes Th2 cell development and increased IL-10 production through modulation of dendritic cells. J. Immunol. 2003;170:4483–4488
  29. Weber MS, Prod'homme T, Youssef S, Dunn SE, Rundle CD, Lee L, et al. Type II monocytes modulate T cell-mediated central nervous system autoimmune disease. Nat. Med. 2007;13:935–943
  30. Zhang M, Chan CC, Vistica B, Hung V, Wiggert B, Gery I. Copolymer 1 inhibits experimental autoimmune uveoretinitis. J. Neuroimmunol. 2000;103:189–194

PII: S0165-5728(09)00306-3

doi: 10.1016/j.jneuroim.2009.08.002

Journal of Neuroimmunology
Volume 215, Issue 1 , Pages 43-48 , 30 October 2009

Article Tools

* Image Usage & Resolution